13F filer · CIK 902219 ↗

Wellington Management Group LLP

You are looking at Q4 2020. See the latest, Q2 2026 →

Reported value

$543.08B

+12% on the quarter before

Positions

1,904

222 new · 190 sold out

Top 10

17.5%

of the value

Est. gain

+$57.16B

on stocks held all quarter

Est. return

+12.9%

on those stocks since Q3 2020

Filed

Feb 12, 2021

On SEC EDGAR ↗

Positions as of Dec 31, 2020, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 31% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2020. Striped tiles are options.

Microsoft2.7%Apple2.4%
Unitedhealth Group Inc2.2%
Alphabet1.8%
Pfizer Inc1.7%
Amazon1.5%
Jpmorgan Chase & Co1.4%
Mcdonalds Corp1.3%
Procter And Gamble Co1.3%
Meta1.3%
Tjx Cos Inc New1.3%
Comcast Corp New1.2%
Eli Lilly1.0%
Johnson & Johnson1.0%
Coca Cola Co1.0%
Bk Of America Corp1.0%
American Express Co0.9%
Danaher Corporation0.9%
Medtronic Plc0.8%
Alibaba0.8%
Home Depot Inc0.8%
Union Pac Corp0.8%
Chubb Limited0.8%
Global Pmts Inc0.8%

Largest buys

Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Morgan Stanley~$1.57BAdded · 0.1% → 0.4%+22,956,884 shares
  2. Eli Lilly~$1.32BAdded · 0.8% → 1.0%+7,830,510 shares
  3. Viatris Inc~$1.31BNew · 0.0% → 0.2%+69,811,210 shares
  4. Baxter Intl Inc~$1.01BAdded · 0.5% → 0.6%+12,620,732 shares
  5. Seagen Inc~$991.7MNew · 0.0% → 0.2%+5,662,148 shares
  6. Schwab Charles Corp~$901.5MAdded · 0.4% → 0.7%+16,997,459 shares
  7. Raytheon Technologies Corp~$797.7MAdded · 0.5% → 0.7%+11,155,762 shares
  8. Amazon~$795.8MAdded · 1.4% → 1.5%+244,352 shares
  9. Vertex Pharmaceuticals Inc~$713.8MAdded · 0.3% → 0.4%+3,020,047 shares
  10. Boston Scientific Corp~$671.0MAdded · 0.5% → 0.5%+18,663,851 shares

Largest sells

Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Intel~$1.52BCut · 0.4% → 0.1%−30,461,066 shares
  2. Apple~$1.34BCut · 2.6% → 2.4%−10,064,961 shares
  3. Deere & Co~$1.16BCut · 0.7% → 0.6%−4,294,151 shares
  4. Seattle Genetics Inc~$1.12BSold out · 0.2% → 0.0%−5,745,112 shares
  5. American Tower~$989.1MCut · 0.8% → 0.5%−4,406,600 shares
  6. Mcdonalds Corp~$983.1MCut · 1.7% → 1.3%−4,581,710 shares
  7. Mylan Nv~$871.0MSold out · 0.2% → 0.0%−58,732,262 shares
  8. PayPal~$827.9MCut · 0.5% → 0.4%−3,534,836 shares
  9. Danaher Corporation~$791.1MCut · 1.1% → 0.9%−3,561,446 shares
  10. Trane Technologies Plc~$757.5MCut · 0.4% → 0.3%−5,218,688 shares

Holdings

As of Dec 31, 2020. Changes are in shares against Sep 30, 2020, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares −4.7% · price +5.7%2.7%$14.57B+$792.0M
AppleCOM · shares −9.1% · price +14.6%2.4%$13.27B+$1.69B
Unitedhealth Group IncCOM · shares −1.0% · price +12.5%2.2%$11.85B+$1.31B
AlphabetCAP STK CL A · shares +5.9% · price +19.6%1.8%$9.51B+$1.47B
Pfizer IncCOM · shares +5.0% · price +0.3%1.7%$9.07B+$25.8M
AmazonCOM · shares +11% · price +3.4%1.5%$7.97B+$238.2M
Jpmorgan Chase & CoCOM · shares +3.4% · price +32.0%1.4%$7.40B+$1.74B
Mcdonalds CorpCOM · shares −12% · price −2.2%1.3%$7.13B−$163.1M
Procter And Gamble CoCOM · shares −3.8% · price +0.1%1.3%$7.11B+$7.7M
MetaCL A · shares +8.8% · price +4.3%1.3%$6.96B+$263.8M
Tjx Cos Inc NewCOM · shares +2.8% · price +22.7%1.3%$6.85B+$1.23B
Comcast Corp NewCL A · shares −0.4% · price +13.3%1.2%$6.40B+$749.5M
Eli LillyCOM · shares +31% · price +14.1%1.0%$5.60B+$527.1M
Johnson & JohnsonCOM · shares +4.9% · price +5.7%1.0%$5.58B+$287.1M
Coca Cola CoCOM · shares −5.0% · price +11.1%1.0%$5.46B+$544.6M
Bk Of America CorpCOM · shares −3.3% · price +25.8%0.99%$5.38B+$1.10B
American Express CoCOM · shares +10% · price +20.6%0.91%$4.93B+$763.2M
Danaher CorporationCOM · shares −14% · price +3.2%0.87%$4.72B+$144.6M
Medtronic PlcSHS · shares −13% · price +12.7%0.83%$4.53B+$510.9M
AlibabaSPONSORED ADS · shares −7.6% · price −20.8%0.82%$4.47B−$1.18B
Home Depot IncCOM · shares −5.6% · price −4.4%0.81%$4.39B−$199.8M
Union Pac CorpCOM · shares −5.6% · price +5.8%0.80%$4.37B+$238.1M
Chubb LimitedCOM · shares +7.8% · price +32.6%0.78%$4.26B+$970.5M
Global Pmts IncCOM · shares −1.4% · price +21.3%0.78%$4.21B+$739.5M
Schwab Charles CorpCOM · shares +29% · price +46.4%0.73%$3.96B+$969.0M
Total · 1,904 positions100%$543.08B+$57.16B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2020 to Q4 2020: 1,627 stocks held throughout, up $57.16B (+12.9%).

  1. Jpmorgan Chase & Co+$1.74B+32%
  2. Apple+$1.69B+15%
  3. Alphabet+$1.47B+20%
  4. Unitedhealth Group Inc+$1.31B+12%
  5. Tjx Cos Inc New+$1.23B+23%
  6. Regeneron Pharmaceuticals−$266.7M−14%
  7. Salesforce−$290.5M−11%
  8. Lockheed Martin Corp−$302.8M−7%
  9. Roku Inc1:14 split−$346.1M−87%
  10. Alibaba−$1.18B−21%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$700.00B$350.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$580.17B+8%SEC ↗
Q1 2026$535.46B−6%SEC ↗
Q4 2025$570.66B−0%SEC ↗
Q3 2025$571.31B+4%SEC ↗
Q2 2025$550.98B+6%SEC ↗
Q1 2025$519.87B−5%SEC ↗
Q4 2024$546.18B−4%SEC ↗
Q3 2024$570.97B+2%SEC ↗
Q2 2024$560.18B−1%SEC ↗
Q1 2024$564.44B+5%SEC ↗
Q4 2023$536.37B+7%SEC ↗
Q3 2023$499.52B−5%SEC ↗
Q2 2023$527.49B+5%SEC ↗
Q1 2023$504.61B+1%SEC ↗
Q4 2022$498.70B+6%SEC ↗
Q3 2022$469.49B−5%SEC ↗
Q2 2022$496.55B−15%SEC ↗
Q1 2022$583.99B−7%SEC ↗
Q4 2021$625.28B+6%SEC ↗
Q3 2021$587.95B−2%SEC ↗
Q2 2021$600.78B+6%SEC ↗
Q1 2021$567.83B+5%SEC ↗
Q4 2020$543.08B+12%SEC ↗
Q3 2020$483.12B+8%SEC ↗
Q2 2020$449.13B+19%SEC ↗
Q1 2020$377.87B−21%SEC ↗
Q4 2019$477.16B+8%SEC ↗
Q3 2019$443.46B−2%SEC ↗
Q2 2019$451.69B+2%SEC ↗
Q1 2019$441.54B+11%SEC ↗
Q4 2018$399.54B−16%SEC ↗
Q3 2018$474.88B+6%SEC ↗
Q2 2018$449.23B+2%SEC ↗
Q1 2018$441.92B−2%SEC ↗
Q4 2017$452.59B+4%SEC ↗
Q3 2017$435.63B+3%SEC ↗
Q2 2017$424.69B+2%SEC ↗
Q1 2017$415.20B+4%SEC ↗
Q4 2016$398.65B−0%SEC ↗
Q3 2016$399.22B+3%SEC ↗
Q2 2016$386.87B+2%SEC ↗
Q1 2016$379.99BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.